Budesonide orodispersible tablets for induction of remission in patients with active eosinophilic oesophagitis: A 6‐week open‐label trial of the EOS‐2 Programme
暂无分享，去创建一个
M. Vieth | A. Bredenoord | A. Schoepfer | A. Straumann | P. Hruz | A. Lucendo | C. Schlag | S. Miehlke | R. Mueller | R. Greinwald | S. Attwood | J. Hayat | L. Biedermann | C. Ciriza de Los Ríos | C. Vaquero | Christoph Schmoecker | Sarah Burrack